News 12's Elizabeth Hashagen was joined by Dr. Sharon Nachman to talk about keeping families healthy this fall and winter.

Doctors should prepare for a possible increase in young patients with enterovirus D68, the Centers for Disease Control and Prevention reported Tuesday, and that may be linked to more cases of the rare, paralyzing condition acute flaccid myelitis.

There was an increase in acute respiratory illnesses and emergency department visits driven by rhinovirus and enterovirus in children and adolescents this summer, new CDC data shows. The rise might be more specifically attributed to enterovirus D68, which, in rare cases, can lead to acute flaccid myelitis, or AFM.

Flu cases fell during the pandemic, but now people are out and about. What do we expect this year? Flu numbers peak from December to February. The American Academy of Pediatrics recommends that children 6 months and older get the shot by the end of October.

Updated COVID-19 boosters could be expanded to younger age groups as soon as early October, a source close to the Food and Drug Administration's planning discussions tells CNN. Moderna and Pfizer both sought FDA emergency use authorization for their updated COVID-19 boosters for younger people in recent days.

Moderna is seeking authorization for children as young as 6 years and Pfizer for children as young as 5. Like the boosters that became available for older people earlier this month, these shots target the original coronavirus strain as well as the Omicron BA.4/BA.5 subvariants. Pfizer's updated booster is currently authorized for use in people 12 and older, and Moderna's is authorized for adults age 18 and older.